Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study.

Saved in:
Bibliographic Details
Title: Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study.
Authors: Lugogo NL; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI., Akuthota P; Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, CA., Sumino K; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO., Burnette AF; Division of Allergy and Immunology, Howard University, Washington, D.C., Mathur SK; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin-Madison, Madison, WI., Lindsley AW; U.S. Medical Affairs, Amgen, Thousand Oaks, CA., Llanos JP; Global Medical Affairs, Amgen, Thousand Oaks, CA., Marchese C; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD., Emmanuel B; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD.
Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2026 May 18. Date of Electronic Publication: 2026 May 18.
Publication Type: Journal Article
Journal Info: Publisher: American Thoracic Society Country of Publication: England NLM ID: 9421642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-4970
DOI:10.1093/ajrccm/aamag225